Literature DB >> 9565364

Mutational analysis of the role of ADP-ribosylation activity and GM1-binding activity in the adjuvant properties of the Escherichia coli heat-labile enterotoxin towards intranasally administered keyhole limpet hemocyanin.

L de Haan1, I K Feil, W R Verweij, M Holtrop, W G Hol, E Agsteribbe, J Wilschut.   

Abstract

The Escherichia coli heat-labile enterotoxin (LT) is known for its potent mucosal immunoadjuvant activity towards co-administered antigens. LT is composed of one A subunit, which has ADP-ribosylation activity, and a homopentameric B subunit, which has high affinity for the toxin receptor, ganglioside GM1. In previous studies, we have investigated the role of the LTA and LTB subunits in the adjuvanticity of LT towards influenza virus hemagglutinin (HA), administered intranasally to mice. We now studied the adjuvant properties of LT and LT variants towards keyhole limpet hemocyanin (KLH), which, in contrast to HA, does not bind specifically to mucosal surfaces. It is demonstrated that LT mutants without ADP-ribosylation activity, as well as LTB, retain mucosal immunoadjuvant activity when administered intranasally to mice in conjunction with KLH. As with influenza HA, adjuvanticity of LTB required GM1-binding activity, whereas GM1-binding was not essential for adjuvant activity of LT. Furthermore, we found that also recombinant LTA alone acts as a potent mucosal adjuvant, and that this adjuvanticity is independent of ADP-ribosylation activity. It is concluded that binding of the antigen to mucosal surfaces does not play an essential role in the immunostimulation by LT and LT variants, and that both recombinant LTA and LTB represent powerful nontoxic mucosal adjuvants.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9565364     DOI: 10.1002/(SICI)1521-4141(199804)28:04<1243::AID-IMMU1243>3.0.CO;2-E

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  12 in total

1.  Mucosal adjuvant properties of mutant LT-IIa and LT-IIb enterotoxins that exhibit altered ganglioside-binding activities.

Authors:  Hesham F Nawar; Sergio Arce; Michael W Russell; Terry D Connell
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

2.  Binding to gangliosides containing N-acetylneuraminic acid is sufficient to mediate the immunomodulatory properties of the nontoxic mucosal adjuvant LT-IIb(T13I).

Authors:  Hesham F Nawar; Charles S Berenson; George Hajishengallis; Hiromu Takematsu; Lorrie Mandell; Ragina L Clare; Terry D Connell
Journal:  Clin Vaccine Immunol       Date:  2010-04-14

3.  Mucosal immunogenicity and adjuvant activity of the recombinant A subunit of the Escherichia coli heat-labile enterotoxin.

Authors:  L De Haan; M Holtrop; W R Verweij; E Agsteribbe; J Wilschut
Journal:  Immunology       Date:  1999-08       Impact factor: 7.397

4.  Genetically detoxified mutants of heat-labile toxin from Escherichia coli are able to act as oral adjuvants.

Authors:  G Douce; V Giannelli; M Pizza; D Lewis; P Everest; R Rappuoli; G Dougan
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

5.  Protective mucosal immunity to ocular herpes simplex virus type 1 infection in mice by using Escherichia coli heat-labile enterotoxin B subunit as an adjuvant.

Authors:  C M Richards; A T Aman; T R Hirst; T J Hill; N A Williams
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

6.  Escherichia coli heat-labile enterotoxin B subunit is a more potent mucosal adjuvant than its vlosely related homologue, the B subunit of cholera toxin.

Authors:  D G Millar; T R Hirst; D P Snider
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

7.  Mutants of type II heat-labile enterotoxin LT-IIa with altered ganglioside-binding activities and diminished toxicity are potent mucosal adjuvants.

Authors:  Hesham F Nawar; Sergio Arce; Michael W Russell; Terry D Connell
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

8.  Recombinant porcine rotavirus VP4 and VP4-LTB expressed in Lactobacillus casei induced mucosal and systemic antibody responses in mice.

Authors:  Xinyuan Qiao; Guiwei Li; Xiangqing Wang; Xiaojing Li; Min Liu; Yijing Li
Journal:  BMC Microbiol       Date:  2009-12-04       Impact factor: 3.605

9.  Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection.

Authors:  R Weltzin; B Guy; W D Thomas; P J Giannasca; T P Monath
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

10.  Construction of prokaryotic expression system of ltB-ureB fusion gene and identification of the recombinant protein immunity and adjuvanticity.

Authors:  Jie Yan; Yuan Wang; Shi-He Shao; Ya-Fei Mao; Hua-Wen Li; Yi-Hui Luo
Journal:  World J Gastroenterol       Date:  2004-09-15       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.